Cargando…

Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade

BACKGROUND: Immunogenicity of SARS-CoV-2 vaccines is modestly impaired in cancer patients due to a generally weakened immune system. Immune checkpoint inhibitors (ICI) are expected to enhance immune response. This has already been described to be the case in influenza vaccines, and first data about...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niewolik, Jacqueline, Mikuteit, Marie, Cossmann, Anne, Vahldiek, Kai, Gutzmer, Ralf, Müller, Frank, Schröder, Dominik, Heinemann, Stephanie, Behrens, Georg M.N., Dopfer-Jablonka, Alexandra, Steffens, Sandra, Grimmelmann, Imke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393793/ https://www.ncbi.nlm.nih.gov/pubmed/35609553 http://dx.doi.org/10.1159/000524894

Ejemplares similares

Soziale Teilhabe und Hautkrebs während der COVID-19-Pandemie
por: Niewolik, Jacqueline, et al.
Publicado: (2023)

The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons – Results of a Multicenter Observational Study
por: Heesen, Gloria, et al.
Publicado: (2022)

Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT)
por: Mikuteit, Marie, et al.
Publicado: (2022)

Feasibility of self-organized blood sample collection in adults for study purposes in a primary care setting
por: Schröder, Dominik, et al.
Publicado: (2023)

Self-reported Tinnitus and Vertigo or Dizziness in a Cohort of Adult Long COVID Patients
por: Degen, Chantal Vanessa, et al.
Publicado: (2022)

SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study
por: Dopfer-Jablonka, Alexandra, et al.
Publicado: (2022)

Social participation and mental health of immunocompromised individuals before and after COVID-19 vaccination–Results of a longitudinal observational study over three time points
por: Heesen, Gloria, et al.
Publicado: (2022)

Audiological profile of adult Long COVID patients
por: Degen, C.V., et al.
Publicado: (2022)

Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial
por: Schröder, Dominik, et al.
Publicado: (2022)

Impfeinstellung, Erwartungen und Impferfahrung von Immunsupprimierten bei COVID-19-Impfungen: Ergebnisse einer Längsschnittstudie
por: Müller, Frank, et al.
Publicado: (2022)

Effects of Pre-Existing Mental Conditions on Fatigue and Psychological Symptoms Post-COVID-19
por: Homann, Stefanie, et al.
Publicado: (2022)

Social participation during the COVID-19 pandemic in persons with a high risk for a severe course of COVID-19 – results of a longitudinal, multi-center observational study in Germany
por: Schröder, Dominik, et al.
Publicado: (2023)

Development and Validation of a Questionnaire to Assess Social Participation of High Risk-Adults in Germany During the COVID-19 Pandemic
por: Schröder, Dominik, et al.
Publicado: (2022)

Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects
por: Mikuteit, Marie, et al.
Publicado: (2023)

How do immunocompromised people experience the changes in their working lives during the COVID-19 pandemic? Results from a mixed-methods study in Germany
por: Wegener, Greta S., et al.
Publicado: (2023)

Healthcare Workers' Perceptions and Medically Approved COVID-19 Infection Risk: Understanding the Mental Health Dimension of the Pandemic. A German Hospital Case Study
por: Kuhlmann, Ellen, et al.
Publicado: (2022)

Health workers’ perception vs medically approved COVID-19 infection risk: the risk communication gap: Ellen Kuhlmann
por: Kuhlmann, E, et al.
Publicado: (2022)

Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study
por: Kuhlmann, Ellen, et al.
Publicado: (2023)

Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients
por: DeTemple, Viola K., et al.
Publicado: (2022)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
por: Jedicke, Nils, et al.
Publicado: (2021)

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
por: Hoffmann, Markus, et al.
Publicado: (2023)

Case Report: Sustained Remission Due to PD-1-Inhibition in a Metastatic Melanoma Patient With Depleted B Cells
por: Wulfken, Lena Margarethe, et al.
Publicado: (2021)

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
por: Kurupati, Raj K., et al.
Publicado: (2018)

Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity
por: Möhn, Nora, et al.
Publicado: (2023)

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
por: Reilley, Matthew J., et al.
Publicado: (2019)

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
por: Hoffmann, Markus, et al.
Publicado: (2022)

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
por: Arora, Prerna, et al.
Publicado: (2022)

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
por: Arora, Prerna, et al.
Publicado: (2022)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients
por: Schaefer, Tim, et al.
Publicado: (2017)

Immunogenic Chemotherapy Sensitizes Renal Cancer to Immune Checkpoint Blockade Therapy in Preclinical Models
por: Cui, Shujin
Publicado: (2017)

Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade
por: Nazerai, Loulieta, et al.
Publicado: (2022)

Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
por: Sriram, Ganapathy, et al.
Publicado: (2022)

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals
por: Behrens, Georg M. N., et al.
Publicado: (2020)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
por: Koch, Elias A. T., et al.
Publicado: (2022)

Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer
por: Fang, Yuhang, et al.
Publicado: (2022)

Triple Combination of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in BRAFV600 Melanoma: Current Status and Future Perspectives
por: Welti, Michèle, et al.
Publicado: (2022)

Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy
por: Möhn, Nora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_it76b3q8sim7cag9kgm2g34va3